Navigation Links
BioDelivery Sciences Provides Business Update and Summary of Third Quarter Results of Operations
Date:11/8/2012

projected peak annual U.S. sales.  Finally, our partnering discussions continue around BNX as we also consider the option of commercializing this product ourselves."

At September 30, 2012, BDSI had $31.3 million in cash compared to $10.8 million at December 31, 2011.  For 2012 year-to-date, BDSI had positive cash flow of $19.7 million compared to negative cash flow in the same period in 2011 of $18.9 million.  In October 2012, BDSI received a $2.5 million milestone payment from Meda as a result of the launch of BREAKYL in Europe. 

Research and development costs in the third quarter 2012 totaled $12.5 million, compared to $6.2 million in the third quarter of 2011.  The increase is due to additional research and development costs associated with the concomitant running of the BEMA Buprenorphine and BEMA Buprenorphine/Naloxone (BNX) Phase 3 trials. 

Third Quarter 2012 and Recent Corporate Update

The following are key events that occurred at BDSI during the third quarter of 2012:

  • BEMA Buprenorphine - Chronic Pain.  BDSI and Endo announced the initiation of the Phase 3 clinical program for BEMA Buprenorphine for the treatment of moderate to severe chronic pain.  The Phase 3 program will consist of two efficacy studies, one in opioid naïve and one in opioid experienced subjects.  Both studies are anticipated to be completed by late 2013 or early 2014.  Both are double-blind, randomized, placebo-controlled, enriched-enrollment studies in patients with chronic lower back pain. 

    BDSI's licensing agreement with Endo for BEMA Buprenorphine calls for milestone payments from Endo at completion of study enrollment and database lock for each trial, and subsequently, upon the acceptance of filing of the New Drug Application (NDA) by the FDA.  These payments would, if achieved, total $30 million.  

    SOURCE BioDelivery Sciences International, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. BioDelivery Sciences Announces Positive Results of Pivotal Pharmacokinetic Study Comparing BEMA Buprenorphine/Naloxone (BNX) to Suboxone
    2. BioDelivery Sciences to Present at the Stifel Nicolaus 2012 Healthcare Conference
    3. BioDelivery Sciences Announces Completion of Enrollment in Pivotal Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone
    4. BioDelivery Sciences to Present at the 2012 Wedbush PacGrow Lifesciences Management Access Conference
    5. BioDelivery Sciences and Endo Health Solutions Announce Initiation of Enrollment in the Phase 3 Program for BEMA Buprenorphine for Chronic Pain
    6. BioDelivery Sciences Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study
    7. Alimera Sciences To Present At Credit Suisse 2012 Healthcare Conference
    8. Particle Sciences Develops Novel Ocular Formulation for Eyeon Therapeutics
    9. Neurocrine Biosciences To Present At Lazard Capitalmarkets 9th Annual Healthcare Conference
    10. Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia
    11. Amarantus BioSciences Appoints Amgen Co-Founder Dr. Joseph Rubinfeld to Advisory Board
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/17/2015)... , April 17, 2015 ... leading Life Science and High Technology company, today ... Pacific headquarters and state-of-the-art Cell Culture ... Park, the facility will provide customized support to ... scientific capabilities. "Our new Technical Center ...
    (Date:4/16/2015)... , April 16, 2015 Vanda Pharmaceuticals ... focused on the development and commercialization of products for ... it will release results for the first quarter of ... closes. The Company will host a ... 6, 2015, during which Vanda management will discuss the ...
    (Date:4/16/2015)... 16, 2015  Hologic, Inc. (NASDAQ: HOLX ... study i published on-line this week in ... the American Cancer Society. The study, ... Pittsburgh Medical Center, supports current consensus guidelines ii ... 30-65 years of age be co-tested with both ...
    Breaking Medicine Technology:Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 2Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 3Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 4Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 5Vanda Pharmaceuticals to Announce First Quarter 2015 Financial Results on May 6, 2015 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 3Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 4
    ... FALLS CHURCH, Va., Oct. 23 -- Today the ... General of the United States Agency for,International Development ... violating federal law by funding nonprofit groups operating,needle ... Organizations affiliated with billionaire political activist George,Soros ...
    ... Hemodynamics and Delay Disease Progression -, CHICAGO, ... positive results from two trials demonstrating that,Tracleer(R) (bosentan) ... therapy,for the treatment of pulmonary arterial hypertension (PAH). ... in combination with sildenafil,is well-tolerated and improves hemodynamics ...
    Cached Medicine Technology:Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups 2Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension 2Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension 3
    (Date:4/18/2015)... NY (PRWEB) April 19, 2015 The ... strong growth during the past five years. The industry, ... who are unable to fully care for themselves, has ... growing need for dementia care for seniors with memory ... rise at an annualized rate of 4.1% to $1.9 ...
    (Date:4/18/2015)... Carinsurancesavings.biz has released a new blog ... cheaper during Spring. , Spring can be a ... should make sure they compare the newest policies before ... learn more about Spring car insurance offers by reading ... quotes are becoming more and more popular. Many insurance ...
    (Date:4/18/2015)... "I wanted to live a ... healthful juice that contained essential vitamins, minerals and ... increases my energy, improves skin elasticity and gives ... Tapp's Juice to contain fruits, vegetables and other ... and mental fatigue. It features a great taste. ...
    (Date:4/18/2015)... April 18, 2015 Lowcostcarinsuranceprice.com has released ... rates have on auto insurance prices . ... rates of vehicle theft may have to pay more ... liability auto insurance policies can also offer protection against ... now be compared online on a single website: ...
    (Date:4/18/2015)... 18, 2015 Thousand of DePuy Pinnacle ... of individuals who were allegedly harmed by a metal-on-metal ... forward in the U.S. District Court, Northern District of ... Court has amended an earlier Case Management Order to ... things, the new amendment permits the claims of up ...
    Breaking Medicine News(10 mins):Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:High Rates Of Car Theft Can Have An Impact on Auto Insurance Prices! 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 3
    ... 25 Videos Airing on Exclusive Statewide On-Demand Channel, ... the winner of the YouCare video contest. Rachel Sbrissa ... video that shares why,she chooses not to smoke. Sbrissa,s ... radiation for lung cancer when the,video was being created, ...
    ... Popular Series Begin Monday, July 14, on ... Television,s Home for Medical Mysteries -, SILVER SPRING, ... emergency room stories to television with,MYSTERY ER, the popular medical ... second season premieres 10 suspense-packed episodes,showcasing the life-threatening drama of ...
    ... - Company Expects to Submit Complete Response by ... 30 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS;,NASDAQ: DDSS) ... response from,the U.S. Food and Drug Administration (FDA) ... the Agency,s Approvable Letter for its once-daily,tramadol formulation ...
    ... insurance consulting service reports that "Republican candidate John ... to buying a computers or cars" saying competition ... care proposal of the presumptive Republican presidential nominee ... employer-sponsored system; it will make things worse, said ...
    ... autism spectrum disorder (ASD) frequently struggle to fit into a world ... find for adults than for children. SIMmersion LLC is hoping ... of its simulation software catered to practicing and strengthening communication skills. ... ...
    ... to reduce pain in newborns undergoing painful procedures ... (venipuncture) for the newborn screening test but not ... co-authors. , In this double-blind, randomized controlled ... Hospital, researchers found that "sucrose reduced overall pain ...
    Cached Medicine News:Health News:Grandmother is Inspiration for Winner of Tobacco Free Florida YouCare Contest 2Health News:MYSTERY ER Season 2 Takes Viewers Behind the Curtain for Real-Life Medical Mysteries on Discovery Health 2Health News:MYSTERY ER Season 2 Takes Viewers Behind the Curtain for Real-Life Medical Mysteries on Discovery Health 3Health News:Labopharm Receives Response from FDA Regarding its Once-Daily Tramadol Product 2Health News:Labopharm Receives Response from FDA Regarding its Once-Daily Tramadol Product 3Health News:Florida Health Insurance Analyst says McCain's Group Health Ideas Bad for Employees 2Health News:Florida Health Insurance Analyst says McCain's Group Health Ideas Bad for Employees 3Health News:New Intervention for Adults with Autism Spectrum Disorder Prototype Completed by SIMmersion LLC 2Health News:New Intervention for Adults with Autism Spectrum Disorder Prototype Completed by SIMmersion LLC 3
    ... Thermal Cyclers provide comprehensive state-of-the-art PCR technology ... instruments for the optimization of sensitive and ... to medium throughput PCR and sequencing applications., ... block allows a choice of consumables: microplates, ...
    ... Techne TC-512 has a graphical touch screen ... experiments at the "touch of a screen." ... linear gradient, Touch Screen, Graphical Display, Memory ... Versatile Block Format, Intuitive Programmin, Free Instrument ...
    ... The Tetrad 2 thermal cycler incorporates a completely ... chassis. As before, the chassis controls four ... is internal, while a large, color LCD allows ... automatic lids -- Moto Alphas -- give high ...
    Dual-bay Dyad thermal cycler chassis, does not include the Alpha units (requires 2)...
    Medicine Products: